Beyond Technology: Using Tech to Improve the Retail Customer Experience

 

The ease of online shopping has put a speed bump in the traditional retail experience. But brick-and-mortar stores are putting on their thinking caps, rolling out massive changes that make shopping an exciting, worthwhile experience. The retail industry is capitalizing on today’s experience driven economy, integrating tech and digital trends to drive engagement and loyalty to the brand. On this episode of Beyond Technology: The Experience Podcast, we explore these technology trends in retail with Amanda Stamm, Project Manager for Acrelec.

So what makes a good in-person shopping experience today, one that will keep the customer coming back for more?

“It’s really all about what you can provide to your customer outside of your product,” Stamm said.

This comes down to curating a personalized experience for each visitor to the store. Stamm expands on this idea, citing her work with big brands like McDonald’s. In her time designing an app for the fast-food giant, she found ways to customize the experience for an enormous demographic and create an app that felt essential and effective for each customer.

But Stamm attests that technology can often hamper a store’s efforts.

“The technology for the sake of technology is where it all falls apart.” she said.

The key to effective tech experiences in retail? — research.

“Managers can sometimes be blind to the issues facing their sales associates,” she said, explaining how just knowing your customer isn’t enough. Brands must also the pain points of their employees.

“Nothing is one size fits all, especially when it comes to technology,” Stamm said, summarizing how each brand is different,with its own set of struggles. But with ample research and testing, technology can be a boon to business and a pleasure for the customer.

For the latest news, videos, and podcasts in the Software & Electronics Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!
Twitter – @TechMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More